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Abstract
Background: Patients with the 22q11.2 deletion syndrome (22qDS) and velopharyngeal dysfunction (VPD) tend to have
residual VPD following surgery. This systematic review seeks to determine whether a particular surgical procedure results in
superior speech outcome or less morbidity.
Methodology/ Principal Findings: A combined computerized and hand-search yielded 70 studies, of which 27 were
deemed relevant for this review, reporting on a total of 525 patients with 22qDS and VPD undergoing surgery for VPD. All
studies were levels 2c or 4 evidence. The methodological quality of these studies was assessed using criteria based on the
Cochrane Collaboration’s tool for assessing risk of bias. Heterogeneous groups of patients were reported on in the studies.
The surgical procedure was often tailored to findings on preoperative imaging. Overall, 50% of patients attained normal
resonance, 48% attained normal nasal emissions scores, and 83% had understandable speech postoperatively. However, 5%
became hyponasal, 1% had obstructive sleep apnea (OSA), and 17% required further surgery. There were no significant
differences in speech outcome between patients who underwent a fat injection, Furlow or intravelar veloplasty, pharyngeal
flap pharyngoplasty, Honig pharyngoplasty, or sphincter pharyngoplasty or Hynes procedures. There was a trend that a
lower percentage of patients attained normal resonance after a fat injection or palatoplasty than after the more obstructive
pharyngoplasties (11–18% versus 44–62%, p = 0.08). Only patients who underwent pharyngeal flaps or sphincter
pharyngoplasties incurred OSA, yet this was not statistically significantly more often than after other procedures (p = 0.25).
More patients who underwent a palatoplasty needed further surgery than those who underwent a pharyngoplasty (50%
versus 7–13%, p = 0.03).
Conclusions/ Significance: In the heterogeneous group of patients with 22qDS and VPD, a grade C recommendation can
be made to minimize the morbidity of further surgery by choosing to perform a pharyngoplasty directly instead of only a
palatoplasty.
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Introduction
The 22q11.2 deletion syndrome (22qDS) is the most frequent
human microdeletion syndrome [1], with a frequency estimated
around 1 in 4000 [2]. There is marked phenotypic heterogeneity
among patients. The most common concerns during infancy
include congenital heart disease, immune disorders, feeding
problems, and hypocalcaemia. In toddlers and school age
children, developmental delay and speech problems surface. In
adolescents and adults psychiatric issues arise [3,4,5].
The speech problems are mostly attributed to velopharyngeal
dysfunction (VPD). The velopharyngeal valve which normally
separates the oral and nasal cavities shows incomplete closure
resulting in feeding difficulties and hypernasal crying in infants and
hypernasal speech in older children. Hypernasality can impair
speech intelligibility with subsequent frustration and social
withdrawal [6]. Language acquisition is often delayed
[7,8,9,10,11,12]. The etiology of VPD in patients with 22qDS
includes palatal defects, adenoid hypoplasia, and platybasia which
enlarge the pharyngeal gap [13]. Furthermore, nasendoscopic
views of attempted velopharyngeal closure show pharyngeal
hypotonia [14].
Patients with hypernasal speech which is resistant to speech
therapy or patients with VPD based on anatomic deficits are
candidates for velopharyngeal surgery. Surgeons aim to correct
VPD by decreasing the size of the velopharyngeal gap by injecting
fat in the posterior pharyngeal wall, lengthening the palate,
mobilizing a pharyngeal flap (PF) that spans the center of the
velopharyngeal gap but retains lateral ports, and/or rotating
lateral flaps to reduce the velopharyngeal port diameter [15].
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There is little evidence guiding the choice between these
procedures.
Theoretically, PFs are only appropriate for patients with good
lateral wall motion [16,17,18,19,20]. When there is good velar
elevation and poor lateral wall motion, a sphincter pharyngoplasty
(SP) or Hynes pharyngoplasty can be used, provided the level of
the flap inset is high enough to provide velopharyngeal
competence [21] and low enough to avoid hyponasality [22].
VPD treatment algorithms based on these theories state that
surgical procedures should be tailored to preoperative findings
such as velopharyngeal gap size and gap shape [15,23,24]. Patients
with coronal closure patterns are predicted to benefit from SP [25]
while patients with sagittal closure patterns are predicted to benefit
from PFs [18,23]. However, these recommendations are not based
on clinical trials or systematic reviews.
Given both the costs and potential complications associated
with surgery, it is important to help surgeons chose which patients
to operate on and which procedure to employ [26]. Clinical trials
comparing PFs to sphincter pharyngoplasties in nonsyndromic
patients show no difference in outcome when treatment allocation
is randomized [16,27,28] or tailored to lateral pharyngeal wall and
velar motion [19,29,30]. Patients with 22qDS were excluded from
these clinical trials, therefore the question whether creating a PF is
more effective than an SP in resolving VPD remains unanswered
for this population.
This study aims to determine whether in patients with 22qDS
and VPD a particular surgical procedure results in a greater
percentage of postoperative normal resonance by systematically
reviewing the available literature. Sub-questions include which
procedure results in less morbidity and whether tailoring the
procedure to preoperative patient characteristics results in superior
outcome. Ideally, these questions should be answered in a clinical
trial. However, patient acquisition rates necessitate multi-center
collaboration [31], and surgeon preferences for certain procedures
limit participation [16]. This retrospective study contributes to
further insight in the outcome of different surgical procedures.
Methods
Ethics
No ethical approval was required to conduct a systematic review
of the literature. Approval was granted by the Institutional Review
Board at the University Hospital in Leuven, Belgium to include
unpublished data from a chart review.
Searching
No protocol exists for this systematic review, nor was such a
protocol prospectively registered in the Cochrane database.
Studies were found via computerized searches of the MEDLINE
and EMBASE databases and the Cochrane CENTRAL Register
of Controlled Trials on 11-11-11. The search syntax included
synonyms of 22qDS (Di-George OR DiGeorge OR ‘‘Di George’’
OR velocardiofacial OR 22q11* OR del22q11* OR ‘‘velo-cardio-
facial’’ OR Shprintzen OR ‘‘catch 22’’) and surgery for VPD ((fat
AND inject*) OR palatoplast* OR Furlow pharyngoplast* OR
velopharyngo* OR ‘‘pharyngeal flap’’ OR Honig OR Hynes). No
limits were imposed on publication type, date, or language.
Additionally, references of the relevant studies were hand-checked
to confirm that no relevant publications were missed by the
electronic search. Finally, data from personal unpublished files was
included.
Selection
The search hits were scanned for relevance using the inclusion
criteria: (1) report outcome after surgery for VPD, and (2) report
separate results for patients with 22qDS. Where relevance could
not be determined based on title and abstract, the full-text was
assessed.
Validity assessment
The methodological quality of each study was appraised using
criteria based on the Cochrane Collaboration’s tool for assessing
risk of bias in therapeutic studies [32]. One point was accredited
for each positive criterion: (1) genetic confirmation of 22qDS, (2)
inclusion of all patients with 22qDS and VPD who underwent
surgery at the center, (3) the choice for the specific surgical
procedure was randomized, (4) speech outcome was assessed at
least one year postoperatively for all patients, (5) speech assessors
were blinded to the surgical procedure, (6) the speech test was
validated, and (7) results included the number of patients with
postoperative normalized resonance. Patient inclusion criteria
were collected to determine whether the study results could be
generalized to all patients with 22qDS with VPD requiring
surgery. Outcome assessment at least one year postoperatively was
considered important since resonance takes at least a year to
stabilize after surgery [21,33,34,35,36].
Data abstraction
Data abstraction was completed independently. When patients
with isolated VPD or other syndromes with VPD were included in
studies, only data from patients with 22qDS and VPD were
included in this review. Data was collected from the studies
including patient age at surgery, prevalence of palatal anomalies,
details of the preoperative imaging and whether this was used to
tailor the procedure, specifics on the surgery, the length of
postoperative follow-up time until speech was assessed, and speech
outcome variables. The surgery was considered tailored when
preoperative imaging studies affected the surgeon’s choice for a
particular surgical technique. For example, only patients with
good pharyngeal lateral wall adduction received PFs, or the
amount of pharyngeal lateral wall adduction determined the PF
width.
Surgical procedures were categorized as either fat injection,
Furlow, intravelar veloplasty (IVP), PF, Honig, SP, or Hynes. In a
Honig procedure a velar retropositioning is combined with the
creation of a PF. The pedicle of the flap tubes postoperatively,
minimizing the obstruction [37]. A Hynes procedure is derived
from a SP with high inset of the lateral flaps implying splitting of
the palate [24].
Non-standardized reporting of speech scores impeded compar-
ison of preoperative baseline characteristics and postoperative
outcome, and different definitions were used to indicate ‘im-
proved’ speech. Therefore, it was not possible to inventory the
degree of preoperative VPD. Yet, where possible, the numbers of
patients with postoperative normal perceptual resonance, nasal
emission, and understandable speech were distilled from the
studies. The definition of normal scores differed per study,
introducing a bias that may affect the cumulative evidence.
Quantitative data synthesis
To compare the outcome of the various procedures, the
percentage of patients who attained normal perceptual resonance,
normal nasal emissions, understandable speech, hyponasal speech,
obstructive sleep apnea (OSA), and those requiring further surgery
were included in a weighted ANOVA with weights based on the
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number of patients each outcome was measured in. Where there
were significant differences, these were further tested using
contrasts with a Bonferroni correction. The following pairs were
compared: 1) fat injection versus Furlow or IVP since these less
obstructive procedures tend to be performed on patients with some
velopharyngeal movement, 2) fat injection versus SP or Hynes
since both augment the posterior pharyngeal wall, 3) fat injection,
Furlow, or IVP versus PF, Honig, SP, or Hynes since the previous
tend to be less obstructive than the latter, 4) Furlow, or IVP versus
PF, Honig, SP, or Hynes to compare palatoplasties to pharyngo-
plasties, 5) PF versus Honig to compare the effect of differing flap
width to creating a narrow PF combined with palatal retro-
positioning, and 6) PF versus SP or Hynes, and 7) Honig versus SP
or Hynes to compare the different types of pharyngoplasties. No
assessment of publication bias was done.
Results
Search and selection
After filtering for duplicates, this electronic search strategy
yielded 70 studies (Figure 1). Thirty-nine studies were excluded
that did not report postoperative speech outcome. Hand-checking
references yielded seven additional studies that report postoper-
ative outcome but were missed by the electronic search because a
synonym of 22qDS was not mentioned in the title or abstract, but
only in the body text [38,39,40,41] or a table [32,33,34]. For two
of the relevant studies, only the abstracts have been published,
hampering data extraction [42,43]. Eleven studies were excluded
that did not report separate results for patients with 22qDS. The
authors have personal access to data from another relevant article
which is still in press but has already been published in a
dissertation [44] and to data from the University Hospital in
Leuven, Belgium (Hens and Vander Poorten, co-authors). The
combined electronic and hand-search strategy yielded 27 relevant
studies for which data was accessible for analysis.
Validity assessment
None of the studies met all the criteria indicating good
methodological quality (Table S1). Genetic confirmation of the
deletion was not always performed or reported. In most studies
only a specific subgroup of patients who underwent surgery for
VPD was reported. The choice for a particular surgical procedure
was not randomized in any study. In only eight studies was the
follow-up time at least one year for all patients. When loss to
follow-up was reported, it ranged from 0–34%. In ten studies the
outcomes of multiple surgical procedures were reported. In three
Figure 1. Study selection. Computerized search conducted on 11-11-11.
doi:10.1371/journal.pone.0034332.g001
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of these studies the speech assessor was blinded to the surgical
procedure [24,45,46].
In five studies postoperative speech was only reported in terms
of improvement without data on the number of patients with
normalization of resonance [33,39,46,47,48]. In three studies
resonance was not one of the postoperative outcome measures
[49,50,51]. These eight studies could not be used to answer the
main question of this review, namely, whether a particular surgical
technique leads to a higher percentage of patients with normal
resonance postoperatively. However, these studies were still
included in the analyses since they reported on the morbidity of
the procedures.
In a handful of studies the inter- or intrarater reliability for the
speech test were reported, indicating the validity of the test
[21,45,50,52,53]. Others used the previously validated Cleft Audit
Protocol for Speech [24] or Pittsburgh Weighted Speech Score
[44,48,54]. No formal validation has been done for the Borel-
Maisonny scale [33,55,56], the SISL (Screening Instrument for
Cleft Palate Speech in Leuven) [Hens and Vander Poorten,
unpublished data], or the test developed by the Dutch Association
for Cleft and Craniofacial Anomalies [57].
Most study designs were outcomes research evaluating the
speech of patients with 22qDS and VPD after undergoing surgery
which is considered level 2c evidence [58]. Three studies were
cohort studies in which patients with 22qDS and VPD who
underwent surgery and those who did not were followed up.
However, these studies were of poor quality deeming them level 4
evidence [58] due to ascertainment bias in recruiting patients to
participate in the study [45], loss to follow-up .20% [6], or
because follow-up times were not reported [59].
Data from all studies were used to determine which surgical
procedure was most effective for resolving VPD in patients with
22qDS.
Study characteristics
A comparison of the characteristics of the 27 studies, further
subdivided by the groups of patients undergoing different
procedures, revealed marked heterogeneity regarding which
patients underwent surgery, the preoperative imaging, and the
postoperative outcome measurements (Table 1, Table S2). Study
sizes ranged from 1 to 44 patients. Many patients had palatal
anomalies (57%, n= 282/494). Some had previous surgery on the
palate or pharynx (n= 25) [35,44,53,54,55,56,57] or adenoid or
tonsils removed (n= 69)[Hens and Vander Poorten, unpublished
data] [6,35,44,48,53,54,57,59,60]. The patients included in the
study by Argamaso et al [61] underwent surgery when they were
on average twice as old as the patients in the other studies.
Pre-operative imaging included nasendoscopy and/or X-ray
cephalograms or (video)fluoroscopy to confirm VPD or assess
pharyngeal movement, including pharyngeal lateral wall motion,
velar movement, gap size on attempted closure, and the closure
pattern. Patients who underwent fat injections or palatoplasties
tended to have better movement and smaller gap sizes than
patients who underwent pharyngoplasties (Table S2).
The course of the carotid arteries was noted during nasendo-
scopy, using magnetic resonance imaging [21,33,35,44,54,56], or
intra-operatively. When an aberrant medialized course was found,
some considered this a contraindication for surgery [33], other
created a narrow PF [59], others suggested a palatoplasty would be
safer than a pharyngoplasty [24], and others stated it had no
consequence for the subsequent therapy [44].
At most centers the data accrued from imaging studies were
used to tailor the surgery. Only patients who underwent a Honig
velopharyngoplasty did not have a tailored surgery, Therefore, no
subanalyses were performed comparing the outcomes of patients
whose surgeries were tailored to those whose surgeries were not
tailored.
In total, postoperative outcome was reported for 525 patients.
Nearly half of the patients underwent a PF procedure. Lipson et al
[6] did not specify what kind of pharyngoplasty was performed,
but this was likely a PF since this was the most popular procedure
in the early 1990s. Postoperative follow-up ranged from 0.2–19.4
years. Resonance was rated based on perceptual assessments by
speech therapists using 2 to 20 point scales. Nasal emissions were
assessed by auscultation or with mirrors and rated on 2 to 20 point
scales. In some studies nasometry was used to assess the percentage
of nasal resonance. Understandability was rated based on
perceptual speech using 2 to 5 point scales or percentage scores.
OSA was inventoried based on patient history, with subsequent
polysomnography if necessary [44,48,54,62]. In some studies
speech outcome was reported following primary surgery for VPD
and further surgery was recommended [49,51,59,62], while in
other studies speech outcome was reported following further
surgery[Hens and Vander Poorten, unpublished data]
[24,25,36,44,47,48,51,54,55,56,57].
Quantitative data synthesis
Overall, 50% of patients attained normal resonance, 48%
attained normal nasal emissions scores, and 83% had understand-
able speech postoperatively. However, 5% became hyponasal, 1%
had obstructive sleep apnea, and 17% required further surgery
(Table 2, Figure 2). The standard deviations were large for many
outcomes, and the variability between the standard deviations was
large for the percentages with OSA and those needing further
surgery (Levene’s test p,0.05).
The diversity of quality, design, and patient populations of the
included studies precluded a fixed or randomized meta-analysis.
The heterogeneity could not be corrected for using a meta-
regression since much data was missing, such as the amount of
velopharyngeal movement. However, in an attempt to gain insight
into overall trends in outcome, data was pooled according to the
surgical procedures, grouping Furlow with IVP since both are
palatoplasties, and SP with Hynes since the techniques differ only
slightly. Widdershoven et al [44] report on 33 patients who
underwent a PF and 7 patients who underwent an SP, but do not
report the outcomes separately. The outcomes of all 40 patients
were included in the PF group. For patients who underwent both a
palatoplasty and a pharyngoplasty, most outcome measures were
counted toward the pharyngoplasty groups. However, the need for
further surgery was counted toward the palatoplasty group when
this was part of the two-staged approach [24,48].
Weighted ANOVA testing showed no significant differences
with regard to speech outcome between the five procedure groups.
There was a trend for the patients who attained normal resonance
to differ between the groups (p = 0.08), with a lower percentage of
patients attaining normal resonance after a fat injection or
palatoplasty (11–18%) than after the more obstructive pharyngo-
plasties (44–62%).
Only patients who underwent PFs or SPs incurred OSA, yet this
was not statistically significantly more often than after other
procedures (p = 0.25).
The need for further surgery differed significantly between the
five procedure groups (p = 0.04). Further testing with the contrasts
and Bonferroni correction revealed that the difference was only
significant between the patients who underwent a palatoplasty and
those who underwent a pharyngoplasty (50% versus 7–13%,
p= 0.03).
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Discussion
By systematically reviewing the available literature, data were
presented and analyzed from 27 studies including 525 patients
with 22qDS and VPD who underwent surgical correction. All
surgeries except the Honig were tailored based on preoperative
imaging. Overall, 50% of patients attained normal resonance.
Fewer patients who underwent only a palatoplasty tended to attain
normal resonance and more needed had a greater need for further
surgery compared to than patients who underwent a pharyngo-
plasty. Therefore, the evidence suggests that for patients with
22qDS and VPD the morbidity of further surgery can be
minimized when the cleft team decides a pharyngoplasty should
be performed directly instead of only a palatoplasty. This is also
the feeling the senior surgeon authors (ABM, VVP, GH) of this
manuscript hold. VVP almost always chooses an extensive
modified Honig procedure with supraperiosteal retropositioning
and a cranially-based large PF in patients with 22qDS.
Limitations
As aforementioned, questions about treatment efficacy should
ideally be answered in a clinical trial. In a multi-center
randomized controlled trial with nonsyndromic patients, 146
patients per procedure group were calculated to be required to
find a 20% difference in outcomes between patients who
underwent a PF and those who underwent a SP. However, the
trial was terminated prematurely due to lower referral rates than
predicted, changes in preoperative assessment leading to referrals
for more nonsurgical interventions, and surgeons’ growing
preference for palate re-repair [16]. Among patients with
22qDS, larger variance is expected, necessitating even more
patients per procedure group.
Given logistic hurdles, a practical solution to gain insight into
trends requires turning to lower level evidence which is
confounded by bias. For example, the 22q11.2 deletion was not
genetically confirmed in all studies, most studies only included a
specific subgroup of patients with 22qDS who required surgery to
treat their VPD, and speech was only tested blindly and using a
validated test in two studies [24,45] (Table S1). The outcome of
some pharyngoplasties may have been wrongly attributed to those
pharyngoplasties since some patients underwent palatoplasties or
multiple pharyngoplasties, either prior to being referred for the
reported procedure [35] or as further surgery [51,57]. Unfortu-
nately, there was no data on the duration and intensity of
postoperative speech therapy. Finally, when data are pooled there
is a chance that the conclusions are misleading [63]. Therefore,
raw data from each study are presented to allow readers to draw
their own conclusions.
Patients
When considering the management of VPD in patients with
22qDS, as for all patients with VPD, there are both conservative
and surgical options. No randomized studies have been conducted
to compare the effect of the natural history of speech development
to the effect of intervention since leaving VPD untreated is
considered ethically unacceptable [64]. Anecdotal experiences
with older patients with VPD who have not have surgery due to
limited resources in developing countries show that VPD does not
resolve spontaneously. Clinical observations indicate that even
minor amounts of VPD do not generally correct themselves and
tend to increase with age [65].
Patients underwent surgery between the ages of 2.4 and 31
years. One may postulate that those undergoing surgery at an
older age may be disadvantaged since compensations are more
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Table 2. Outcomes by procedure. Mean percentage of patients 6 standard deviation (number of studies, number of patients).
Fat Injection Furlow or IVP PF Honig SP or Hynes All
Normal resonance 11624 (2, 9) 18619 (2, 33) 62679 (11, 175) 486100 (3, 86) 446108 (8, 68) 50698 (26, 371)
Normal nasal emissions 336141 (2, 9) 3660 (1, 14) 506124 (5, 118) 51637 (3, 43) 47635 (5, 38) 48679 (16, 222)
Understandable 67671 (2, 9) - (0, 0) 896102 (2, 27) 88673 (2, 50) 25650 (2, 4) 83677 (8, 90)
Hyponasal 060 (1, 3) 760 (1, 14) 4635 (8, 143) 2619 (2, 42) 6630 (9, 100) 5629 (21, 302)
OSA 060 (2, 9) 060 (4, 45) 166 (11, 181) 060 (2, 69) 268 (9, 108) 166 (28, 412)
Needing further surgery 3360 (2, 9) 506154 (6, 54) 7666 (10, 142) 15631 (3, 86) 13634 (9, 94) 17692 (30, 385)
IVP: intravelar veloplasty; PF: pharyngeal flap; SP: sphincter pharyngoplasty.
doi:10.1371/journal.pone.0034332.t002
Figure 2. Outcomes by procedure. A) Normal resonance. B) Normal nasal emissions. C) Understandable. D) Hyponasal. E) OSA. F) Needing further
surgery.
doi:10.1371/journal.pone.0034332.g002
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ingrained and their brains have less plasticity to relearn speaking
techniques. Yet, when tested, age was not found to predict speech
outcome [57] nor the need for further surgery [47].
All children receive speech and language therapy. When this
insufficiently corrects VPD due to anatomic deficits, the
velopharyngeal gap can be decreased in size by obturation with
a prosthesis, inserting autologous or synthetic materials, or
surgically. The clinical and radiological characteristics of the
patient and the velopharyngeal function guide the clinician’s
treatment choice. Prosthetics are bothersome and less effective
than surgery, as proven in a randomized controlled trial among
syndromic and nonsyndromic children with moderate to severe
VPD [66] or with a hypodynamic pharynx [67].
In many studies, the indication for surgery was not specified
beyond ‘‘VPD.’’ When the degree of preoperative VPD was
reported (n= 13 studies), the lack of a universal scale hampered
comparison between studies. However, in three studies the
outcomes after different procedures were reported (n= 3 studies)
[Hens and Vander Poorten, unpublished data] [24,48], allowing
comparison of baseline VPD between patients that underwent
different procedures. In the study by Rottgers et al. [48], patients
who primarily underwent a Furlow procedure had an average
Pittsburgh Weighted Speech Score of 18.4, while patients who
primarily received a PF the average score was 26.8 [48]. In the
studies by Hens and Vander Poorten[unpublished data] and
Mehendale et al. [24] no group averages were reported, but each
patient was rated on a 5 point scale, making it more difficult to
summarize the data. In the study by Hens and Vander
Poorten[unpublished data], 50% of the patients who underwent
a Hynes procedure (n = 2) had severely hypernasal speech, while
65% of the patients who underwent a Honig procedure (n = 17)
had severely hypernasal speech. In the study by Mehendale et al.
[24], there was one patient with severely hypernasal speech in
each group. One patient who underwent both an IVP and a
Hynes procedure was not hypernasal and did not have any nasal
emission or turbulence preoperatively but only had mild VPD on
nasendoscopy. These baseline differences likely affect outcome: a
greater degree of preoperative nasalance is prognostic for an
increased need for further surgery [47].
Imaging
At some centers, preoperative imaging is assessed with the
assumption that the velopharyngeal closure pattern should dictate
the procedure choice [18] or the amount of velopharyngeal
movement should affect the operative technique. However, both
the assessment of the imaging and the extrapolation to a specific
surgical procedure are imperfect. Using standardized assessment
of nasendoscopic views of velopharyngeal movement [68],
interrater reliability was only 0.4 for semi-quantitative judgment
of velar and lateral wall motion, and even lower for characteristics
that were measured qualitatively [69]. Similarly, interrater
agreement was ,0.5 among routine assessors of videofluoroscopy
[70], but .0.8 in another center [71,72].
Furthermore, both the amount and pattern of velopharyngeal
motion [17,39,70,71,73,74,75] and the dimensions of a PF [76]
change after surgery, compromising the logic of tailoring
procedures and/or techniques based on preoperative findings.
Among syndromic and nonsyndromic children the amount of
lateral wall adduction is not correlated with outcome [76]. In this
systematic review, patients who had more favorable velopharyn-
geal movement underwent less obstructive surgeries (Table S2),
Compared to their counterparts who had less favorable velopha-
ryngeal movement and underwent more obstructive pharyngo-
plasties, fewer patients who underwent less obstructive fat
injections or palatoplasties attained normal resonance and more
patients required further surgery.
Surgical procedures
Ideally, an operation is based on anatomic and physiologic
knowledge and clinical trials to test the hypothesis [31]. In a
cadaver study, Huang et al [22] reason that the palatoplasty is the
most physiological solution to restore velopharyngeal function
when there is a cleft palate with maloriented muscles as it
reinstates the sling mechanism of the levator veli palatini muscles.
When there is VPD despite the correct positioning of the palatal
muscles, a pharyngoplasty is often required. A SP is said to
preserve the sphincter function of the superior constrictor while
augmenting the thickness of the pharyngeal walls, decreasing the
velopharyngeal port size [46]. Creating a PF, conversely, disrupts
the pharyngeal sphincter mechanism by dividing the superior
constrictor muscle [22]. However, the flap donor site on the
posterior pharyngeal wall heals by circular contraction [77],
possibly causing the muscle fibers to migrate medially [78].
The results from trials among patients without 22qDS should
not be simply be extrapolated to this unique group [48,53]. Lipson
et al [6] lament that a standard repair of an overt or submucous
cleft was never adequate to prevent VPD in patients with 22qDS.
Having VPD and any syndrome is associated with having a
hypodynamic velopharynx [67] and is prognostic for poorer
postoperative outcome [39]. Lower primary success rates for all
patients with hypodynamic velopharynges, including those with
22qDS, supports the logic of segregating this group (which
constitutes up to 25% of the population with VPD) from the
larger cleft palate population [67]. In general, the speech outcome
after surgery has been reported to be worse in patients with 22qDS
than in patients without the syndrome [25,36,47,49,56,79,80,81],
but some patients with 22qDS fare as well as their non-syndromic
counterparts [33,39,40,46,52,61,82].
Treating VPD in any patients with hypo- or adynamic
velopharynges, including nonsyndromic patients and patients with
other syndromes, is a challenge. A study comparing outcomes
reported 42% (n= 15/36) failure after primary treatment among
patients with a hypodynamic velopharynx and only 13% (n= 16/
119) failure among patients with a dynamic velopharynx [67].
Treatment algorithms suggest creating a SP in patients with a
hypodynamic pharynx [15,23]. However, in patients with
neurologic VPD, PFs and SPs have similar outcomes [29,83].
The choice which surgical technique to employ is largely based
on the surgeon’s preference [67]. Forty-eight percent of surgeons
who answered a questionnaire (n = 13/27) create PFs in over half
of their patients with 22qDS [51]. This systematic review confirms
this predilection for PFs. Some prefer to create a PF [53], stating
the outcome is superior because the procedure is simpler and the
results are less variable than after a SP [84]. Others prefer a SP
above a wide PF because the latter has an increased risk of OSA
[18,23,24,47,67]. Finally, one center recommends a two-staged
approach and waiting six months between a palatoplasty and
pharyngoplasty to determine whether the need for a pharyngo-
plasty has been resolved or allow a less obstructive pharyngoplasty
to be created [24,85].
Surgical techniques
Not all palatoplasties, PFs, or SPs are the same. A palatoplasty
can include a Z-plasty [39,46,48,49,81] or varying degrees of
dissection and repositioning of the levator veli palatini muscles
[24]. A PF can be cranially [33,50] or caudally based [60]. A
palatoplasty with supraperiosteal retropositioning of the velar sling
can be combined with a PF in a (modified) Honig procedure
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[37,41]. The PF donor site can be closed [21,54,72,73,84] or left
to heal by secondary intention [21] thereby allowing scar
constriction to decrease the pharyngeal width [71]. The width of
PFs can be varied by lining [17,54] or shortening [61] the flap to
prevent tubing [86]. Even then, the eventual flap width is
unpredictable [61,72,76,87], compromising the logic of tailoring
the technique based on velopharyngeal movement. During an SP,
the width of the flaps [25,53], the height of inset [24,25,53,62] and
the amount of overlap of the two lateral flaps [47,80] can be
varied.
In this systematic review, despite the differences in technique,
Furlows and IVPs were not separated since both are palatoplasties
in which no material is added and the levator veli palatini muscles
are positioned as physiologically as possible. SPs and Hynes were
not separated since in both procedures lateral flaps are created,
rotated, and inset on the posterior pharyngeal wall. For both SP
and Hynes, the height of inset was tailored to the level of
attempted velopharyngeal contact.
Outcome
Definitions of success differ [25]. Since the indication for a
corrective surgery is VPD, the goal should be resolution of VPD
while avoiding overcorrection and the need for further surgery
[47]. As Furlow Jr. so strongly stated, ‘‘there are no points for
‘significant improvement’ … near-miss successes in one institution
may not be classified the same in another; they make inter-
institutional comparisons of questionable validity’’ [39]. Certainly
this systematic review has questionable validity due to the
differences in reporting between centers. We attempted to bypass
the different definitions by including only numbers of patients with
normalized resonance. Undoubtedly, the definition of normalcy
also differs between centers.
None of the interventions in current use is completely successful
in correcting VPD. The low rate of normal resonance may be
attributed to the short postoperative follow-up after which the full
effect of speech therapy has not yet been achieved [57].
The low rate of normal resonance may reflect the purposeful
creation of less obstruction to prevent OSA. OSA is a possible
serious complication following pharyngoplasty [65] and is
associated with pharyngeal hypotonia [26]. Patients with 22qDS
with hypotonia who undergo surgical correction of VPD are
therefore particularly at risk for developing OSA [77,88,89,90].
Despite surgeons’ fears of inducing OSA, we found only 4 cases
in these studies. Interestingly, OSA did not occur more frequently
among patients receiving PFs (n = 2) than those receiving SPs
(n = 2). In one case, the OSA resolved within 3 weeks on nasally
applied continuous positive airway pressure [62]. The others had
further surgery to increase the velopharyngeal port size. No OSA
occurred when a palatoplasty and pharyngoplasty were performed
in one stage [46] nor at centers where the two-stage approach is
employed [24,48].
Further surgery may be needed when there is residual VPD
[24,36,48,49,55,56,57,59,62] or OSA [44,47,54]. Whether it is
carried out depends on the recommendation of the cleft team and
the patients’ or their family’s desires [25,54,62]. The increased
need for further surgery among patients who underwent a
palatoplasty is affected by the deliberate two-staged approach.
There were no significant differences in speech outcomes or
morbidity between the groups that underwent different types of
pharyngoplasties. It is unclear whether this reflects the appropri-
ateness of tailoring based on velopharyngeal movement, or
whether the procedures have similar efficacy despite differences
in velopharyngeal movement.
Conclusion
Based on outcomes research (level 2c evidence) and poor quality
cohort studies (level 4 evidence), a Grade C recommendation [58]
can be made to minimize the morbidity of further surgery for
patients with 22qDS and VPD by choosing to perform a
pharyngoplasty directly. Only performing a palatoplasty resulted
in a greater need for further surgery. Higher level evidence is
needed to confirm or refute these findings. While a randomized
controlled trial seems unfeasible, by conducting prospective cohort
studies at multiple centers and uniformly documenting patient
characteristics, velopharyngeal movement, and outcome measures,
a meta-analysis could be performed with correction for the various
factors.
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Cochrane Collaboration’s tool for assessing risk of
bias[32].
(DOC)
Table S2 Imaging modalities and assessments.
(DOC)
Acknowledgments
The authors would like to thank Paul Westers for giving expert advice
regarding statistical calculations.
Author Contributions
Conceived and designed the experiments: NES ABM. Performed the
experiments: NES. Analyzed the data: NES JRH GH. Contributed
reagents/materials/analysis tools: NES VVP ABM. Wrote the paper: NES
JRH GH VVP ABM. Critically revised the manuscript for important
intellectual content: JRH GH VVP ABM.
References
1. Saitta SC, Harris SE, Gaeth AP, Driscoll DA, McDonald-McGinn DM, et al.
(2004) Aberrant interchromosomal exchanges are the predominant cause of the
22q11.2 deletion. Hum Mol Genet 13: 417–428.
2. Devriendt K, Fryns JP, Mortier G, van Thienen MN, Keymolen K (1998) The
annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 35:
789–790.
3. Kobrynski LJ, Sullivan KE (2007) Velocardiofacial syndrome, DiGeorge
syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370:
1443–1452.
4. McDonald-McGinn DM, Sullivan KE (2011) Chromosome 22q11.2 deletion
syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Balti-
more) 90: 1–18.
5. Shprintzen RJ (2008) Velo-cardio-facial syndrome: 30 Years of study. Dev
Disabil Res Rev 14: 3–10.
6. Lipson AH, Yuille D, Angel M, Thompson PG, Vandervoord JG, et al. (1991)
Velocardiofacial (Shprintzen) syndrome: an important syndrome for the
dysmorphologist to recognise. J Med Genet 28: 596–604.
7. Dyce O, McDonald-McGinn D, Kirschner RE, Zackai E, Young K, et al. (2002)
Otolaryngologic manifestations of the 22q11.2 deletion syndrome. Arch
Otolaryngol Head Neck Surg 128: 1408–1412.
8. Eliez S, Palacio-Espasa F, Spira A, Lacroix M, Pont C, et al. (2000) Young
children with Velo-Cardio-Facial syndrome (CATCH-22). Psychological and
language phenotypes. Eur Child Adolesc Psychiatry 9: 109–114.
9. Gerdes M, Solot C, Wang PP, Moss E, LaRossa D, et al. (1999) Cognitive and
behavior profile of preschool children with chromosome 22q11.2 deletion.
Am J Med Genet 85: 127–133.
10. Persson C, Niklasson L, Oskarsdottir S, Johansson S, Jonsson R, et al. (2006)
Language skills in 5–8-year-old children with 22q11 deletion syndrome.
Int J Lang Commun Disord 41: 313–333.
Velopharyngeal Dysfunction in 22q11.2DS
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e34332
11. Scherer NJ, D’Antonio LL, Kalbfleisch JH (1999) Early speech and language
development in children with velocardiofacial syndrome. Am J Med Genet 88:
714–723.
12. Van Lierde KM, Mortier G, Loeys B, Baudonck N, De Ley S, et al. (2007)
Overall intelligibility, language, articulation, voice and resonance characteristics
in a child with Shprintzen-Goldberg syndrome. Int J Pediatr Otorhinolaryngol
71: 721–728.
13. Widdershoven JC, Beemer FA, Kon M, Dejonckere PH, Mink van der
Molen AB (2008) Possible mechanisms and gene involvement in speech
problems in the 22q11.2 deletion syndrome. J Plast Reconstr Aesthet Surg 61:
1016–1023.
14. Ysunza A, Carmen Pamplona M, Santiago Morales MA (2011) Velopharyngeal
valving during speech, in patients with velocardiofacial syndrome and patients
with non-syndromic palatal clefts after surgical and speech pathology
management. Int J Pediatr Otorhinolaryngol 75: 1255–1259.
15. Sie KC, Chen EY (2007) Management of velopharyngeal insufficiency:
development of a protocol and modifications of sphincter pharyngoplasty.
Facial Plast Surg 23: 128–139.
16. Abyholm F, D’Antonio L, Davidson Ward SL, Kjoll L, Saeed M, et al. (2005)
Pharyngeal flap and sphincterplasty for velopharyngeal insufficiency have equal
outcome at 1 year postoperatively: results of a randomized trial. Cleft Palate
Craniofac J 42: 501–511.
17. Argamaso RV, Shprintzen RJ, Strauch B, Lewin ML, Daniller AI, et al. (1980)
The role of lateral pharyngeal wall movement in pharyngeal flap surgery. Plast
Reconstr Surg 66: 214–219.
18. Armour A, Fischbach S, Klaiman P, Fisher DM (2005) Does velopharyngeal
closure pattern affect the success of pharyngeal flap pharyngoplasty? Plast
Reconstr Surg 115: 45–52; discussion 53.
19. Lam E, Hundert S, Wilkes GH (2007) Lateral pharyngeal wall and velar
movement and tailoring velopharyngeal surgery: determinants of velopharyn-
geal incompetence resolution in patients with cleft palate. Plast Reconstr Surg
120: 495–505; discussion 506–507.
20. Schmelzeisen R, Hausamen JE, Loebell E, Hacki T (1992) Long-term results
following velopharyngoplasty with a cranially based pharyngeal flap. Plast
Reconstr Surg 90: 774–778.
21. Arneja JS, Hettinger P, Gosain AK (2008) Through-and-through dissection of
the soft palate for high pharyngeal flap inset: a new technique for the treatment
of velopharyngeal incompetence in velocardiofacial syndrome. Plast Reconstr
Surg 122: 845–852.
22. Huang MH, Lee ST, Rajendran K (1998) Anatomic basis of cleft palate and
velopharyngeal surgery: implications from a fresh cadaveric study. Plast
Reconstr Surg 101: 613–627; discussion 628–619.
23. Marsh JL (2003) Management of velopharyngeal dysfunction: differential
diagnosis for differential management. J Craniofac Surg 14: 621–628; discussion
629.
24. Mehendale FV, Birch MJ, Birkett L, Sell D, Sommerlad BC (2004) Surgical
management of velopharyngeal incompetence in velocardiofacial syndrome.
Cleft Palate Craniofac J 41: 124–135.
25. Sie KC, Tampakopoulou DA, de Serres LM, Gruss JS, Eblen LE, et al. (1998)
Sphincter pharyngoplasty: speech outcome and complications. Laryngoscope
108: 1211–1217.
26. Goldberg S, Shatz A, Picard E, Wexler I, Schwartz S, et al. (2005) Endoscopic
findings in children with obstructive sleep apnea: effects of age and hypotonia.
Pediatr Pulmonol 40: 205–210.
27. Ysunza A, Pamplona C, Ramirez E, Molina F, Mendoza M, et al. (2002)
Velopharyngeal surgery: a prospective randomized study of pharyngeal flaps
and sphincter pharyngoplasties. Plast Reconstr Surg 110: 1401–1407.
28. Ysunza A, Pamplona MC, Molina F, Drucker M, Felemovicius J, et al. (2004)
Surgery for speech in cleft palate patients. Int J Pediatr Otorhinolaryngol 68:
1499–1505.
29. Peat BG, Albery EH, Jones K, Pigott RW (1994) Tailoring velopharyngeal
surgery: the influence of etiology and type of operation. Plast Reconstr Surg 93:
948–953.
30. Ysunza A, Pamplona MC, Mendoza M, Molina F, Martinez P, et al. (2001)
Surgical treatment of submucous cleft palate: a comparative trial of two
modalities for palatal closure. Plast Reconstr Surg 107: 9–14.
31. Marsh JL, Grames LM, Holtman B (1989) Intravelar veloplasty: a prospective
study. Cleft Palate J 26: 46–50.
32. (2011) Cochrane Handbook for Systematic Reviews of Interventions. In:
Higgins JPT, Green S, eds. Version 5.1.0 ed: The Cochrane Collaboration.
33. Rouillon I, Leboulanger N, Roger G, Maulet M, Marlin S, et al. (2009)
Velopharyngoplasty for noncleft velopharyngeal insufficiency: results in relation
to 22q11 microdeletion. Arch Otolaryngol Head Neck Surg 135: 652–656.
34. Conley SF, Gosain AK, Marks SM, Larson DL (1997) Identification and
assessment of velopharyngeal inadequacy. Am J Otolaryngol 18: 38–46.
35. Tatum SA, 3rd, Chang J, Havkin N, Shprintzen RJ (2002) Pharyngeal flap and
the internal carotid in velocardiofacial syndrome. Arch Facial Plast Surg 4:
73–80.
36. Widdershoven JC, Stubenitsky BM, Breugem CC, MinkvanderMolen AB (2008)
Outcome of velopharyngoplasty in patients with velocardiofacial syndrome.
Arch Otolaryngol Head Neck Surg 134: 1159–1164.
37. Mink van der Molen AB, Janssen K, Specken TF, Stubenitsky BM (2008) The
modified Honig velopharyngoplasty - a new technique to treat hypernasality by
palatal lenghtening. J Plast Reconstr Aesthet Surg.
38. Husein M, Chang E, Cable B, Karnell M, Karnell LH, et al. (2004) Outcomes
for children with submucous cleft palate and velopharyngeal insufficiency.
J Otolaryngol 33: 222–226.
39. Perkins JA, Lewis CW, Gruss JS, Eblen LE, Sie KC (2005) Furlow palatoplasty
for management of velopharyngeal insufficiency: a prospective study of 148
consecutive patients. Plast Reconstr Surg 116: 72–80; discussion 81–74.
40. Pryor LS, Lehman J, Parker MG, Schmidt A, Fox L, et al. (2006) Outcomes in
pharyngoplasty: a 10-year experience. Cleft Palate Craniofac J 43: 222–225.
41. Seagle MB, Mazaheri MK, Dixon-Wood VL, Williams WN (2002) Evaluation
and treatment of velopharyngeal insufficiency: the University of Florida
experience. Ann Plast Surg 48: 464–470.
42. Ghanem AM, Gilleard O, Sell D, Birch M, Sommerlad BC (2011) Speech
outcome following anatomical muscle dissection velar repair of the Submucous
cleft palate (SMCP) in patients with velocardiofacial syndrome (VCFS).
Molecular Syndromology 1: 209.
43. Solot C, Kohut A, McDonald-McGinn D, Zackai E, Kirschner R (2011) Is there
an optimal age for velopharyngeal dysfunction repair in the 22q11.2 deletion
syndrome? Molecular Syndromology 1: 195.
44. Widdershoven JCC, Solot CB, McDonald-McGinn DM, Zackai EH,
Kirschner RE (In press) Surgical management of velopharyngeal dysfunction
in patients with 22q11.2 deletion syndrome. Cleft Palate Craniofac J.
45. Baylis AL, Munson B, Moller KT (2008) Factors affecting articulation skills in
children with velocardiofacial syndrome and children with cleft palate or
velopharyngeal dysfunction: a preliminary report. Cleft Palate Craniofac J 45:
193–207.
46. Milczuk HA, Smith DS, Brockman JH (2007) Surgical outcomes for
velopharyngeal insufficiency in velocardiofacial syndrome and nonsyndromic
patients. Cleft Palate Craniofac J 44: 412–417.
47. Losken A, Williams JK, Burstein FD, Malick DN, Riski JE (2006) Surgical
correction of velopharyngeal insufficiency in children with velocardiofacial
syndrome. Plast Reconstr Surg 117: 1493–1498.
48. Rottgers SA, Ford M, Cray J, Smith D, Kinsella C, et al. (2011) An algorithm for
application of furlow palatoplasty to the treatment of velocardiofacial syndrome-
associated velopharyngeal insufficiency. Ann Plast Surg 66: 479–484.
49. D’Antonio LL, Davio M, Zoller K, Punjabi A, Hardesty RA (2001) Results of
Furlow Z-plasty in patients with velocardiofacial syndrome. Plast Reconstr Surg
107: 1077–1079.
50. Wang G, Wang K, Chen Y, Yang Y, Wu Y, et al. (2009) Sequential treatment of
speech disorders in velocardiofacial syndrome patients: an 8-year retrospective
evaluation. J Craniofac Surg 20 Suppl 2: 1934–1938.
51. Witt PD, Miller DC, Marsh JL, Muntz HR, Grames LM (1998) Limited value of
preoperative cervical vascular imaging in patients with velocardiofacial
syndrome. Plast Reconstr Surg 101: 1184–1195; discussion 1196–1189.
52. Brandao GR, de Souza Freitas JA, Genaro KF, Yamashita RP, Fukushiro AP, et
al. (2011) Speech outcomes and velopharyngeal function after surgical treatment
of velopharyngeal insufficiency in individuals with signs of velocardiofacial
syndrome. J Craniofac Surg 22: 1736–1742.
53. Ysunza A, Pamplona MC, Molina F, Hernandez A (2009) Surgical planning for
restoring velopharyngeal function in velocardiofacial syndrome. Int J Pediatr
Otorhinolaryngol 73: 1572–1575.
54. Swanson EW, Sullivan SR, Ridgway EB, Marrinan EM, Mulliken JB (2011)
Speech outcomes following pharyngeal flap in patients with velocardiofacial
syndrome. Plast Reconstr Surg 127: 2045–2053.
55. Leuchter I, Schweizer V, Hohlfeld J, Pasche P (2009) Treatment of
velopharyngeal insufficiency by autologous fat injection. Eur Arch Otorhinolar-
yngol.
56. Nicolas L, Marion B, Francoise D, Fergal G, Jean-Baptiste C, et al. (2011)
Autologous fat transfer in velopharyngeal insufficiency: Indications and results of
a 25 procedures series. Int J Pediatr Otorhinolaryngol.
57. Spruijt NE, Widdershoven JC, Breugem C, Speleman L, Homveld IL, et al.
(2011) Velopharyngeal dysfunction and 22q11.2 deletion syndrome: A
longitudinal study of functional outcome and preoperative prognostic factors.
Cleft Palate Craniofac J.
58. Phillips B (1998) Oxford Centre for Evidence-based Medicine - Levels of
Evidence. Oxford.
59. MacKenzie-Stepner K, Witzel MA, Stringer DA, Lindsay WK, Munro IR, et al.
(1987) Abnormal carotid arteries in the velocardiofacial syndrome: a report of
three cases. Plast Reconstr Surg 80: 347–351.
60. Goorhuis-Brouwer SM, Dikkers FG, Robinson PH, Kerstjens-Frederikse WS
(2003) Specific language impairment in children with velocardiofacial syndrome:
four case studies. Cleft Palate Craniofac J 40: 190–195.
61. Argamaso RV, Levandowski GJ, Golding-Kushner KJ, Shprintzen RJ (1994)
Treatment of asymmetric velopharyngeal insufficiency with skewed pharyngeal
flap. Cleft Palate Craniofac J 31: 287–294.
62. Witt P, Cohen D, Grames LM, Marsh J (1999) Sphincter pharyngoplasty for the
surgical management of speech dysfunction associated with velocardiofacial
syndrome. Br J Plast Surg 52: 613–618.
63. Reade MC, Delaney A, Bailey MJ, Angus DC (2008) Bench-to-bedside review:
avoiding pitfalls in critical care meta-analysis–funnel plots, risk estimates, types
of heterogeneity, baseline risk and the ecologic fallacy. Crit Care 12: 220.
64. Riski JE (1979) Articulation skills and oral-nasal resonance in children with
pharyngeal flaps. Cleft Palate J 16: 421–428.
Velopharyngeal Dysfunction in 22q11.2DS
PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e34332
65. Graham WP, 3rd, Hamilton R, Randall P, Winchester R, Stool S (1973)
Complications following posterior pharyngeal flap surgery. Cleft Palate J 10:
176–180.
66. Marsh JL, Wray RC (1980) Speech prosthesis versus pharyngeal flap: a
randomized evaluation of the management of velopharyngeal incompetency.
Plast Reconstr Surg 65: 592–594.
67. Witt PD, Marsh JL, Marty-Grames L, Muntz HR, Gay WD (1995)
Management of the hypodynamic velopharynx. Cleft Palate Craniofac J 32:
179–187.
68. Golding-Kushner KJ, Argamaso RV, Cotton RT, Grames LM, Henningsson G,
et al. (1990) Standardization for the reporting of nasopharyngoscopy and
multiview videofluoroscopy: a report from an International Working Group.
Cleft Palate J 27: 337–347; discussion 347–348.
69. Sie KC, Starr JR, Bloom DC, Cunningham M, de Serres LM, et al. (2008)
Multicenter interrater and intrarater reliability in the endoscopic evaluation of
velopharyngeal insufficiency. Arch Otolaryngol Head Neck Surg 134: 757–763.
70. Witt PD, Myckatyn T, Marsh JL, Grames LM, Pilgram TK (1998) Does
preexisting posterior pharyngeal wall motion drive the dynamism of sphincter
pharyngoplasty? Plast Reconstr Surg 101: 1457–1462.
71. Karling J, Henningsson G, Larson O, Isberg A (1999) Adaptation of pharyngeal
wall adduction after pharyngeal flap surgery. Cleft Palate Craniofac J 36:
166–172.
72. Karling J, Henningsson G, Larson O, Isberg A (1999) Comparison between two
types of pharyngeal flap with regard to configuration at rest and function and
speech outcome. Cleft Palate Craniofac J 36: 154–165.
73. Shprintzen RJ, McCall GN, Skolnick ML (1980) The effect of pharyngeal flap
surgery on the movements of the lateral pharyngeal walls. Plast Reconstr Surg
66: 570–573.
74. Lewis MB, Pashayan HM (1980) The effects of pharyngeal flap surgery on
laternal pharyngeal wall motion: a videoradiographic evaluation. Cleft Palate J
17: 301–308.
75. Zwitman DH (1982) Oral endoscopic comparison of velopharyngeal closure
before and after pharyngeal flap surgery. Cleft Palate J 19: 40–46.
76. Vandevoort MJ, Mercer NS, Albery EH (2001) Superiorly based flap
pharyngoplasty: the degree of postoperative ‘‘tubing’’ and its effect on speech.
Br J Plast Surg 54: 192–196.
77. Shprintzen RJ (1988) Pharyngeal flap surgery and the pediatric upper airway.
Int Anesthesiol Clin 26: 79–88.
78. Barone CM, Shprintzen RJ, Strauch B, Sablay LB, Argamaso RV (1994)
Pharyngeal flap revisions: flap elevation from a scarred posterior pharynx. Plast
Reconstr Surg 93: 279–284.
79. D’Antonio LL, Scherer NJ, Miller LL, Kalbfleisch JH, Bartley JA (2001)
Analysis of speech characteristics in children with velocardiofacial syndrome
(VCFS) and children with phenotypic overlap without VCFS. Cleft Palate
Craniofac J 38: 455–467.
80. Losken A, Williams JK, Burstein FD, Malick D, Riski JE (2003) An outcome
evaluation of sphincter pharyngoplasty for the management of velopharyngeal
insufficiency. Plast Reconstr Surg 112: 1755–1761.
81. Sie KC, Tampakopoulou DA, Sorom J, Gruss JS, Eblen LE (2001) Results with
Furlow palatoplasty in management of velopharyngeal insufficiency. Plast
Reconstr Surg 108: 17–25; discussion 26–19.
82. Meek MF, Coert JH, Hofer SO, Goorhuis-Brouwer SM, Nicolai JP (2003)
Short-term and long-term results of speech improvement after surgery for
velopharyngeal insufficiency with pharyngeal flaps in patients younger and older
than 6 years old: 10-year experience. Ann Plast Surg 50: 13–17.
83. Davison PM, Razzell RE, Watson AC (1990) The role of pharyngoplasty in
congenital neurogenic speech disorders. Br J Plast Surg 43: 187–196.
84. Chegar BE, Shprintzen RJ, Curtis MS, Tatum SA (2007) Pharyngeal flap and
obstructive apnea: maximizing speech outcome while limiting complications.
Arch Facial Plast Surg 9: 252–259.
85. Sommerlad BC, Mehendale FV, Birch MJ, Sell D, Hattee C, et al. (2002) Palate
re-repair revisited. Cleft Palate Craniofac J 39: 295–307.
86. Lin KY, Goldberg D, Williams C, Borowitz K, Persing J, et al. (1999) Long-term
outcome analysis of two treatment methods for cleft palate: combined levator
retropositioning and pharyngeal flap versus double-opposing Z-plasty. Cleft
Palate Craniofac J 36: 73–78.
87. Keuning KH, Meijer GJ, van der Bilt A, Koole R (2009) Revisional surgery
following the superiorly based posterior pharyngeal wall flap. Historical
perspectives and current considerations. Int J Oral Maxillofac Surg 38:
1137–1142.
88. Agarwal T, Sloan GM, Zajac D, Uhrich KS, Meadows W, et al. (2003) Speech
benefits of posterior pharyngeal flap are preserved after surgical flap division for
obstructive sleep apnea: experience with division of 12 flaps. J Craniofac Surg
14: 630–636.
89. Kravath RE, Pollak CP, Borowiecki B, Weitzman ED (1980) Obstructive sleep
apnea and death associated with surgical correction of velopharyngeal
incompetence. J Pediatr 96: 645–648.
90. Sher AE, Shprintzen RJ, Thorpy MJ (1986) Endoscopic observations of
obstructive sleep apnea in children with anomalous upper airways: predictive
and therapeutic value. Int J Pediatr Otorhinolaryngol 11: 135–146.
Velopharyngeal Dysfunction in 22q11.2DS
PLoS ONE | www.plosone.org 11 March 2012 | Volume 7 | Issue 3 | e34332
